Oct 24 (Reuters) - Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused tumors to ...
A crowd of South African men ran through the streets of Johannesburg in purple swim briefs to raise awareness about prostate ...
5don MSN
This Test Can Tell You If Something’s Up With Your Prostate. So Why Aren’t Guys Getting It?
Improvements in the PSA screening process make it worth another look.
A French early-access program of 3,709 patients with metastatic castration-resistant prostate cancer found that ...
Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An ...
ORION CORPORATION PRESS RELEASE 24 OCTOBER 2026 at 9.35 EEST Darolutamide plus ADT and radiation therapy reduces risk of ...
A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.
Prostate cancer is the most common cancer in men – in 2013, it affected more than one million men across the world.
Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.5 million men in the United States who have been diagnosed with prostate ...
Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes were associated with the future risk of developing prostate cancer, including aggressive ...
Daily Mail on MSN
Scientists discover a way to spot men at risk of prostate cancer more than a DECADE before symptoms
In the largest study of its kind, Oxford University researchers uncovered 12 proteins linked to the cancer after testing ...
Early-stage studies presented at ESMO reported promising activity for several experimental treatments for advanced prostate cancer. Johnson & Johnson’s oral JNJ-6143 produced substantial PSA declines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results